Dicarboxylicaminoaciduria
Dicarboxylicaminoaciduria: Introduction
Dicarboxylicaminoaciduria: A rare metabolic syndrome involving a defect in the transport of certain amino acids (glutamate, aspartate) and resulting in high levels of dicarboxylic amino acids in the urine. Often no observable symptoms occur.
More detailed information about the symptoms,
causes, and treatments of Dicarboxylicaminoaciduria is available below.
Symptoms of Dicarboxylicaminoaciduria
Read more about symptoms of Dicarboxylicaminoaciduria
Home Diagnostic Testing
Home medical testing related to Dicarboxylicaminoaciduria:
- Bladder & Urinary Health: Home Testing:
- more...»
Wrongly Diagnosed with Dicarboxylicaminoaciduria?
Causes of Dicarboxylicaminoaciduria
Read more about causes of Dicarboxylicaminoaciduria.
Less Common Symptoms of Dicarboxylicaminoaciduria
Read more about symptoms of Dicarboxylicaminoaciduria
Dicarboxylicaminoaciduria: Undiagnosed Conditions
Commonly undiagnosed diseases in related medical categories:
Misdiagnosis and Dicarboxylicaminoaciduria
Interstitial cystitis an under-diagnosed bladder condition: The medical
condition of interstitial cystitic is a bladder condition that can be
misdiagnosed as various conditions such as overactive bladder or other causes of...read more »
Read more about Misdiagnosis and Dicarboxylicaminoaciduria
Dicarboxylicaminoaciduria: Research Doctors & Specialists
Research related physicians and medical specialists:
- Urinary & Bladder Specialists (Urology):
- Kidney Health Specialists (Nephrology):
- more specialists...»
Other doctor, physician and specialist research services:
Statistics for Dicarboxylicaminoaciduria
Dicarboxylicaminoaciduria: Broader Related Topics
Types of Dicarboxylicaminoaciduria
User Interactive Forums
Read about other experiences, ask a question about Dicarboxylicaminoaciduria, or answer someone else's question, on our message boards:
Definitions of Dicarboxylicaminoaciduria:
Dicarboxylicaminoaciduria is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Dicarboxylicaminoaciduria, or a subtype of Dicarboxylicaminoaciduria,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Dicarboxylicaminoaciduria as a "rare disease".
Source - Orphanet
Contents for Dicarboxylicaminoaciduria: